Cardiovascular
539 FDA-approved drugs
Recent Approvals
MYQORZO
AFICAMTEN
adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacit...
2025-12-19
CYTOKINETICS
LEROCHOL
LERODALCIBEP-LIGA
LEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein choles...
2025-12-12
LIB THERAPEUTICS, INC.
PCSK9
IOHEXOL
IOHEXOL
intrathecal, intra-arterial, intravenous, oral, rectal, intraarticular and body cavity imaging proce...
2025-11-13
AMNEAL
JAVADIN
CLONIDINE HYDROCHLORIDE
hypertension in adult patients, to lower blood pressure...
2025-10-23
AZURITY
LASIX ONYU
FUROSEMIDE
edema in adult patients with chronic heart failure...
2025-10-07
SQ INNOVATION
ENBUMYST
BUMETANIDE
edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic s...
2025-09-12
CORSTASIS THERAP
ZOLYMBUS
BIMATOPROST
the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular ...
2025-09-09
THEA PHARMA
CANGRELOR
CANGRELOR
Cangrelor for injection is indicated as an adjunct to percutaneous coronary intervention (PCI) to re...
2025-08-11
GLAND
SDAMLO
AMLODIPINE BESYLATE
hypertension, to lower blood pressure in adults and pediatric patients 6 years of age and older...
2025-07-24
BRILLIAN PHARMA
VOSTALLY
RAMIPRIL
hypertension, to lower blood pressure...
2025-07-23
ROSEMONT PHARMS
DEHYDRATED ALCOHOL
DEHYDRATED ALCOHOL
1 INDICATIONS & USAGE Dehydrated alcohol injection is indicated to induce controlled cardiac septal ...
2025-06-23
ROYAL PHARMS
ARYNTA
LISDEXAMFETAMINE DIMESYLATE
( 1 ): Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and ...
2025-06-16
AZURITY
YUTREPIA
TREPROSTINIL SODIUM
pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability...
2025-05-23
LIQUIDIA TECH
LATANOPROSTENE BUNOD
LATANOPROSTENE BUNOD
the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertens...
2025-04-29
GLAND
ELIQUIS SPRINKLE
APIXABAN
DVT...
2025-04-17
Bristol-Myers Squibb
THROMBIN
HEMICLOR
CHLORTHALIDONE
hypertension in adults, to lower blood pressure...
2025-03-17
PRM PHARMA
ARBLI
LOSARTAN POTASSIUM
hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure...
2025-03-13
SCIENTURE
BUCAPSOL
BUSPIRONE HYDROCHLORIDE
the management of anxiety disorders or the short-term relief of the symptoms of anxiety...
2025-03-13
EPIC PHARMA LLC
RIVAROXABAN
RIVAROXABAN
Rivaroxaban tablet is a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular ev...
2025-03-03
ALEMBIC
THROMBIN
DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
DILTIAZEM HYDROCHLORIDE
hypertension...
2025-02-21
HQ SPCLT PHARMA
Showing 20 of 539 drugs
Top Companies
Drug Classes
Thiazide Diuretic 25
Radiographic Contrast Agent 10
Prostaglandin Analog 10
Angiotensin 2 Receptor Blocker 8
alpha-Adrenergic Agonist 8
Thiazide-like Diuretic 7
Loop Diuretic 6
Dihydropyridine Calcium Channel Blocker 6
HMG-CoA Reductase Inhibitor 6
Endothelin Receptor Antagonist 5
Quick Stats
- Total Drugs
- 539
- Companies
- 175
- Drug Classes
- 56
- Latest Approval
- 2025-12-19